These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28065862)

  • 21. The role of anti-inflammatory drugs and nanoparticle-based drug delivery models in the management of ischemia-induced heart failure.
    Haley KE; Almas T; Shoar S; Shaikh S; Azhar M; Cheema FH; Hameed A
    Biomed Pharmacother; 2021 Oct; 142():112014. PubMed ID: 34391184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gender differences in cardiac function during early remodeling after acute myocardial infarction in mice.
    Cavasin MA; Tao Z; Menon S; Yang XP
    Life Sci; 2004 Sep; 75(18):2181-92. PubMed ID: 15325844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Berberine plays a cardioprotective role by inhibiting macrophage Wnt5a/β-catenin pathway in the myocardium of mice after myocardial infarction.
    Tian CX; Li MY; Shuai XX; Jiang F; Dong YL; Gui Y; Zhang ZL; Qin RJ; Kang ZY; Lin L; Sarapultsev A; Wu B; Luo SS; Hu DS
    Phytother Res; 2023 Jan; 37(1):50-61. PubMed ID: 36218220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TVP1022: A Novel Cardioprotective Drug Attenuates Left Ventricular Remodeling After Ischemia/Reperfusion in Pigs.
    Malka A; Meerkin D; Barac YD; Malits E; Bachner-Hinenzon N; Carasso S; Ertracht O; Angel I; Shofti R; Youdim M; Abassi Z; Binah O
    J Cardiovasc Pharmacol; 2015 Aug; 66(2):214-22. PubMed ID: 25900266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanoformulation and Evaluation of Oral Berberine-Loaded Liposomes.
    Duong TT; Isomäki A; Paaver U; Laidmäe I; Tõnisoo A; Yen TTH; Kogermann K; Raal A; Heinämäki J; Pham TM
    Molecules; 2021 Apr; 26(9):. PubMed ID: 33946815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coptisine exert cardioprotective effect through anti-oxidative and inhibition of RhoA/Rho kinase pathway on isoproterenol-induced myocardial infarction in rats.
    Gong LL; Fang LH; Wang SB; Sun JL; Qin HL; Li XX; Wang SB; Du GH
    Atherosclerosis; 2012 May; 222(1):50-8. PubMed ID: 22387061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DPP-4 inhibition attenuates cardiac dysfunction and adverse remodeling following myocardial infarction in rats with experimental diabetes.
    Connelly KA; Zhang Y; Advani A; Advani SL; Thai K; Yuen DA; Gilbert RE
    Cardiovasc Ther; 2013 Oct; 31(5):259-67. PubMed ID: 22963483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanoparticle-Mediated Delivery of Pitavastatin to Monocytes/Macrophages Inhibits Left Ventricular Remodeling After Acute Myocardial Infarction by Inhibiting Monocyte-Mediated Inflammation.
    Mao Y; Koga JI; Tokutome M; Matoba T; Ikeda G; Nakano K; Egashira K
    Int Heart J; 2017 Aug; 58(4):615-623. PubMed ID: 28701679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chitosan-Coated Solid Lipid Nano-Encapsulation Improves the Therapeutic Antiairway Inflammation Effect of Berberine against COPD in Cigarette Smoke-Exposed Rats.
    Liu H; Li Y; Zhang X; Shi M; Li D; Wang Y
    Can Respir J; 2022; 2022():8509396. PubMed ID: 35465190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allopurinol attenuates left ventricular remodeling and dysfunction after experimental myocardial infarction: a new action for an old drug?
    Engberding N; Spiekermann S; Schaefer A; Heineke A; Wiencke A; Müller M; Fuchs M; Hilfiker-Kleiner D; Hornig B; Drexler H; Landmesser U
    Circulation; 2004 Oct; 110(15):2175-9. PubMed ID: 15466649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of perindopril on left ventricular remodeling and myocardial osteopontin expression in rats with myocardial infarction].
    Zhang YL; Zhou SX; Wang MH; Wang JF
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov; 26(11):1584-8. PubMed ID: 17121705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic Akt1 deficiency attenuates adverse remodeling and enhances angiogenesis after myocardial infarction.
    Vandoorne K; Vandsburger MH; Raz T; Shalev M; Weisinger K; Biton I; Brumfeld V; Raanan C; Nevo N; Eilam R; Hemmings BA; Tzahor E; Harmelin A; Gepstein L; Neeman M
    Circ Cardiovasc Imaging; 2013 Nov; 6(6):992-1000. PubMed ID: 24134954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A steroid receptor coactivator stimulator (MCB-613) attenuates adverse remodeling after myocardial infarction.
    Mullany LK; Rohira AD; Leach JP; Kim JH; Monroe TO; Ortiz AR; Stork B; Gaber MW; Sarkar P; Sikora AG; Rosengart TK; York B; Song Y; Dacso CC; Lonard DM; Martin JF; O'Malley BW
    Proc Natl Acad Sci U S A; 2020 Dec; 117(49):31353-31364. PubMed ID: 33229578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Qiliqiangxin improves cardiac function and attenuates cardiac remodeling in rats with experimental myocardial infarction.
    Wang J; Zhou J; Ding X; Zhu L; Jiang K; Fu M; Wang S; Hu K; Ge J
    Int J Clin Exp Pathol; 2015; 8(6):6596-606. PubMed ID: 26261541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Corydalis hendersonii Hemsl. protects against myocardial injury by attenuating inflammation and fibrosis via NF-κB and JAK2-STAT3 signaling pathways.
    Bai R; Yin X; Feng X; Cao Y; Wu Y; Zhu Z; Li C; Tu P; Chai X
    J Ethnopharmacol; 2017 Jul; 207():174-183. PubMed ID: 28629818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardioprotective role of growth/differentiation factor 1 in post-infarction left ventricular remodelling and dysfunction.
    Bao MW; Zhang XJ; Li L; Cai Z; Liu X; Wan N; Hu G; Wan F; Zhang R; Zhu X; Xia H; Li H
    J Pathol; 2015 Jul; 236(3):360-72. PubMed ID: 25726944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of angiotensin-converting enzyme 2 accelerates maladaptive left ventricular remodeling in response to myocardial infarction.
    Kassiri Z; Zhong J; Guo D; Basu R; Wang X; Liu PP; Scholey JW; Penninger JM; Oudit GY
    Circ Heart Fail; 2009 Sep; 2(5):446-55. PubMed ID: 19808375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody against interleukin-6 receptor attenuates left ventricular remodelling after myocardial infarction in mice.
    Kobara M; Noda K; Kitamura M; Okamoto A; Shiraishi T; Toba H; Matsubara H; Nakata T
    Cardiovasc Res; 2010 Aug; 87(3):424-30. PubMed ID: 20211866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac overexpression of monocyte chemoattractant protein-1 in transgenic mice prevents cardiac dysfunction and remodeling after myocardial infarction.
    Morimoto H; Takahashi M; Izawa A; Ise H; Hongo M; Kolattukudy PE; Ikeda U
    Circ Res; 2006 Oct; 99(8):891-9. PubMed ID: 16990567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amelioration of cardiac dysfunction and ventricular remodeling after myocardial infarction by danhong injection are critically contributed by anti-TGF-β-mediated fibrosis and angiogenesis mechanisms.
    Chen J; Cao W; Asare PF; Lv M; Zhu Y; Li L; Wei J; Gao H; Zhang H; Mao H; Gao X; Fan G
    J Ethnopharmacol; 2016 Dec; 194():559-570. PubMed ID: 27729285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.